Epalrestat
Epalrestat No CAS: 82159-09-9 Epalrestat
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se utiliza para prevenir, mejorar y tratar la neuropatía periférica (entumecimiento, dolor), parestesia vibracional y anomalías cardíacas asociadas con la diabetes. ESPECIFICACIÓN
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat se utiliza para prevenir, mejorar y tratar la neuropatía periférica (entumecimiento, dolor), parestesia vibracional y anomalías cardíacas asociadas con la diabetes. ESPECIFICACIÓN
P nombre roduct | Epalrestat |
CAS | 82159-09-9 Epalrestat |
MF: | C15H13NO3S2 |
MW: | 319,4 |
Escriba aquí su mensaje y envíenoslo